Article thumbnail

Conjugates of Superoxide Dismutase 1 with Amphiphilic Poly(2-oxazoline) Block Copolymers for Enhanced Brain Delivery: Synthesis, Characterization and Evaluation in Vitro and in Vivo

By Jing Tong (333418), Xiang Yi (529951), Robert Luxenhofer (2006884), William A. Banks (314965), Rainer Jordan (1991146), Matthew C. Zimmerman (580637) and Alexander V. Kabanov (404729)


Superoxide dismutase 1 (SOD1) efficiently catalyzes dismutation of superoxide, but its poor delivery to the target sites in the body, such as brain, hinders its use as a therapeutic agent for superoxide-associated disorders. Here to enhance the delivery of SOD1 across the blood–brain barrier (BBB) and in neurons the enzyme was conjugated with poly­(2-oxazoline) (POx) block copolymers, P­(MeOx-<i>b</i>-BuOx) or P­(EtOx-<i>b</i>-BuOx), composed of (1) hydrophilic 2-methyl-2-oxazoline (MeOx) or 2-ethyl-2-oxazoline (EtOx) and (2) hydrophobic 2-butyl-2-oxazoline (BuOx) repeating units. The conjugates contained from 2 to 3 POx chains joining the protein amino groups via cleavable -(ss)- or noncleavable -(cc)- linkers at the BuOx block terminus. They retained 30% to 50% of initial SOD1 activity, were conformationally and thermally stable, and assembled in 8 or 20 nm aggregates in aqueous solution. They had little if any toxicity to CATH.a neurons and displayed enhanced uptake in these neurons as compared to native or PEGylated SOD1. Of the two conjugates, SOD1-(cc)-P­(MeOx-<i>b</i>-BuOx) and SOD1-(cc)-P­(EtOx-<i>b</i>-BuOx), compared, the latter was entering cells 4 to 7 times faster and at 6 h colocalized predominantly with endoplasmic reticulum (41 ± 3%) and mitochondria (21 ± 2%). Colocalization with endocytosis markers and pathway inhibition assays suggested that it was internalized through lipid raft/caveolae, also employed by the P­(EtOx-<i>b</i>-BuOx) copolymer. The SOD activity in cell lysates and ability to attenuate angiotensin II (Ang II)-induced superoxide in live cells were increased for this conjugate compared to SOD1 and PEG-SOD1. Studies in mice showed that SOD1–POx had ca. 1.75 times longer half-life in blood than native SOD1 (28.4 vs 15.9 min) and after iv administration penetrated the BBB significantly faster than albumin to accumulate in brain parenchyma. The conjugate maintained high stability both in serum and in brain (77% vs 84% at 1 h postinjection). Its amount taken up by the brain reached a maximum value of 0.08% ID/g (percent of the injected dose taken up per gram of brain) 4 h postinjection. The entry of SOD1-(cc)-P­(EtOx-<i>b</i>-BuOx) to the brain was mediated by a nonsaturable mechanism. Altogether, SOD1–POx conjugates are promising candidates as macromolecular antioxidant therapies for superoxide-associated diseases such as Ang II-induced neurocardiovascular diseases

Topics: Biophysics, Biochemistry, Medicine, Cell Biology, Molecular Biology, Neuroscience, Pharmacology, Biotechnology, Cancer, Mental Health, Hematology, Chemical Sciences not elsewhere classified, Superoxide Dismutase 1, 3 POx chains, BuOx block terminus, 20 nm aggregates, 4 h postinjection, 1 h postinjection, attenuate angiotensin II, SOD 1 activity, VivoSuperoxide dismutase 1, SOD 1, Enhanced Brain Delivery, pathway inhibition assays, PEGylated SOD 1., 6 h colocalized, conjugate, BBB, ID
Year: 2013
DOI identifier: 10.1021/mp300496x.s001
OAI identifier:
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.